Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07178626

Association of Biomarkers and Gastric Antral Motility Index With Feeding Intolerance in Critically Ill Patients

Association of Biomarkers and Gastric Antral Motility Index With Feeding Intolerance in Critically Ill Patients: the BGM-FI Study

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
The First Hospital of Jilin University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

When the subjects are admitted to the department, the researchers will monitor potential biomarkers of gastrointestinal injury before administering enteral nutrition (a small amount of blood is drawn, serum is separated by centrifugation, and the serum sample is frozen for final centralized biomarker detection), and measure the antral movement index under ultrasound (300ml of warm water is injected into the stomach before measurement, and then the antral movement is observed for 6 minutes) Then, monitor whether the patient has developed feeding intolerance within 7 days of the ICU

Conditions

Interventions

TypeNameDescription
OTHERNot applicable- observational studyThis is a prospective observational study and does not involve any intervention measures

Timeline

Start date
2025-10-20
Primary completion
2026-07-31
Completion
2026-12-31
First posted
2025-09-17
Last updated
2026-01-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07178626. Inclusion in this directory is not an endorsement.